N. K. Yılmaz, “Dasatinib as a Repurposing Candidate for Alzheimer’s Disease: An Integrated In Silico Network Pharmacology and Molecular Docking Study”, Trends in Pharmacy, vol. 3, pp. 1–11, Jun. 2026.